Skip to content
Bomb Report – Lifestyle
Author:
Insight Molecular Diagnostics Inc.
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
March 20, 2026
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
March 13, 2026
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
March 6, 2026
←
Previous Page
1
2